Novartis and Schrödinger have entered into a research collaboration and licence agreement worth over $2.4bn to advance ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

Researchers led by the Institute of Cancer Research (ICR) have identified a potential new treatment approach to slow down the ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...

But as AI has become more prevalent, we have started to recognise the advantages and opportunities it offers through a ...